Ignite Creation Date:
2024-05-06 @ 6:43 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05768178
Status:
RECRUITING
Last Update Posted:
2023-10-25
First Post:
2023-02-22
Brief Title:
DETERMINE Trial Treatment Arm 05 Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers
Sponsor:
Cancer Research UK
Organization:
Cancer Research UK
Organization Data
Organization:
Cancer Research UK
Class:
OTHER
Study ID:
CRUKD21004- Treatment Arm 5
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cancer Research UK
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hoffmann-La Roche | INDUSTRY |
| University of Manchester | OTHER |
| University of Birmingham | OTHER |
| Royal Marsden NHS Foundation Trust | OTHER |